Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes ( SPS 3) Trial.
暂无分享,去创建一个
[1] A. Cheung,et al. Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction , 2018, Annals of Internal Medicine.
[2] Anna C. Porter,et al. Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT). , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] G. Bakris,et al. Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk. , 2017, Journal of the American Society of Nephrology : JASN.
[4] Yining Huang,et al. Longitudinal relationship between chronic kidney disease and distribution of cerebral microbleeds in patients with ischemic stroke , 2016, Journal of the Neurological Sciences.
[5] M. Shlipak,et al. Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Randomized Trial. , 2016, Circulation.
[6] C. Escobar Cervantes,et al. [A randomized trial of intensive versus standard blood pressure control]. , 2016, Semergen.
[7] Jiguang Wang,et al. OS 34-04 SAFETY OF EARLY INTENSIVE BLOOD PRESSURE LOWERING IN CEREBRAL SMALL VESSEL DISEASE AND CHRONIC KIDNEY DISEASE IN ACUTE INTRACEREBRAL HEMORRHAGE. , 2016, Journal of hypertension.
[8] K. Toyoda. Cerebral Small Vessel Disease and Chronic Kidney Disease , 2015, Journal of stroke.
[9] A. Cheung,et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] O. Benavente,et al. Clinical–MRI Correlations in a Multiethnic Cohort with Recent Lacunar Stroke: The SPS3 Trial , 2014, International journal of stroke : official journal of the International Stroke Society.
[11] P. Peduzzi,et al. Combined angiotensin inhibition for the treatment of diabetic nephropathy. , 2013, The New England journal of medicine.
[12] R. Conwit,et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial , 2013, The Lancet.
[13] Z. Massy,et al. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. , 2013, Journal of the American Society of Nephrology : JASN.
[14] R. Conwit,et al. The Secondary Prevention of Small Subcortical Strokes (SPS3) Study , 2011, International journal of stroke : official journal of the International Stroke Society.
[15] J. Stockman,et al. A New Equation to Estimate Glomerular Filtration Rate , 2011 .
[16] H. Markus,et al. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.
[17] Kevin A Peterson,et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .
[18] Michiaki Abe,et al. Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk , 2009, Hypertension Research.
[19] S. Yusuf,et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.
[20] B. Palmer. Renal dysfunction complicating the treatment of hypertension. , 2002, The New England journal of medicine.
[21] C. Bregonzio,et al. Protection Against Ischemia and Improvement of Cerebral Blood Flow in Genetically Hypertensive Rats by Chronic Pretreatment With an Angiotensin II AT1 Antagonist , 2002, Stroke.
[22] P. Scheltens,et al. A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.
[23] A Hofman,et al. A follow‐up study of blood pressure and cerebral white matter lesions , 1999, Annals of neurology.
[24] K. Matsushita,et al. Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. , 1994, Hypertension.
[25] D. Heistad,et al. Effect of Antihypertensive Treatment on Focal Cerebral Infarction , 1992, Hypertension.
[26] T. Hedner,et al. Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. , 1992, Blood pressure.